Related Experiment Video
Updated: Nov 3, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Venous Thromboembolism among Critically Ill Children: A Narrative Review
Anthony A Sochet1,2,3, Amy Kiskaddon3,4, Marisol Betensky3,5,6
1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Insights
Hospitalization increases venous thromboembolism (VTE) risk in children, impacting mortality. Routine VTE evaluation is crucial for critically ill children presenting with specific symptoms.
Area of Science:
- Pediatric critical care medicine
- Hematology
- Thrombosis research
Background:
- Venous thromboembolism (VTE) is a significant cause of illness and death in hospitalized children.
- Hospitalization and critical illness elevate VTE risk in pediatric patients, correlating with mortality and long-term health issues.
- VTE rates in critically ill children are influenced by diverse factors including thrombophilia, immobility, and illness severity.
Purpose of the Study:
- To review current literature on VTE in critically ill children.
- To identify risk factors, prevention strategies, clinical presentations, treatments, and outcomes.
- To highlight knowledge gaps and future research priorities, including COVID-19 and multisystem inflammatory disease in children.
Main Methods:
- This narrative review synthesizes existing research on pediatric VTE.
- It examines historical and recent literature on VTE risk, prevention, and management.
- Focus is placed on clinical trial opportunities and challenges in thromboprophylaxis.
Main Results:
- Critically ill children with signs of venous congestion, inflammation, or organ dysfunction require VTE assessment.
- VTE risk is multifactorial, influenced by patient-specific and clinical factors.
- Research into thromboprophylaxis in pediatric populations, including those with COVID-19, is ongoing.
Conclusions:
- Early VTE evaluation is recommended for critically ill children with suggestive signs.
- Further collaborative research is needed to address knowledge gaps in pediatric VTE.
- Understanding and managing VTE in critically ill children is vital for improving outcomes.
Abstract:
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality among hospitalized patients, including children. In recent years, it has become clear that hospitalization and critical illness bestow an increased VTE risk in pediatrics and relate to mortality and life-limiting comorbidities. For critically ill children, reported rates of VTE vary by study sampling techniques, presence of inherited or acquired thrombophilia, acute and chronic immobility, underlying illness prompting hospitalization, and clinical factors related to illness severity such as central venous catheterization, length of stay, mechanical ventilation, and patient age. Accordingly, critically ill children with new signs of venous congestion, acute inflammation, or unexplained acute organ dysfunction should be routinely evaluated for VTE. This narrative review summarizes recent and historical literature regarding risk factors, prevention, presentation, treatment, and outcomes of VTE in critically ill children. In addition, we identify knowledge gaps and priorities for future collaborative research on this vital condition. Special attention is given to the clinical trial opportunities, challenges, and ongoing efforts in thromboprophylaxis in critically ill children, including those hospitalized for disease related to novel coronavirus (COVID-19) and multisystem inflammatory disease in children.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction

